SCWorx Corp. (NASDAQ:WORX)
| Market Cap | 50.56M-92.5% |
| Revenue (ttm) | 2.93M+3.1% |
| Net Income | -2.36M+21.5% |
| EPS | -0.15+73.2% |
| Shares Out | 16.00M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 164,501 |
| Open | 3.42 |
| Previous Close | 3.73 |
| Day's Range | 2.91 - 3.42 |
| 52-Week Range | 2.30 - 118.26 |
| Beta | 1.29 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About WORX
SCWorx Corp., headquartered in New York, New York, is a technology firm primarily dedicated to crafting and marketing advanced information technology solutions and related services for the healthcare industry. Its central aim is to enhance operational efficiency and streamline data flow within hospitals and various medical establishments across the United States. The company delivers a broad spectrum of data-focused services, encompassing the repair, standardization, and interoperability of healthcare information for providers, alongside delivering sophisticated big data analytics for the sector. Its diverse offerings include virtualized item master file repair, expansion, and automation; management of electronic medical records (EMR) and charge description masters (CDM); optimization of contract management; automation of request for proposal (RFP) and rebate processes; integration of acquired management systems; big data analytics modeling; data integration and warehousing; and its proprietary ScanWorx solution. Beyond its core healthcare IT endeavors, SCWorx has diversified into other areas. It operates CageTix, an online event ticketing platform specifically targeting regional mixed martial arts events. Additionally, the company is involved in the provision of personal protective equipment (PPE) and rapid COVID-19 test kits. SCWorx distributes its specialized solutions and services to hospitals and health systems through a multi-channel approach, leveraging both its internal sales team and strategic distribution and reseller partnerships.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$WORX stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in WORX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by WORX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
WORX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
WORX Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Goodwill | $5.84M | 77.90% |
| Cash | $1.26M | 16.85% |
| Accounts receivable, net | $261.76K | 3.49% |
| Legal and professional | $124.17K | 1.66% |
| Property and equipment, net | $8.45K | 0.11% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New WORX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to WORX from public contracts
Source: USAspending.gov
WORX Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from WORX’s recent data — informational, not investment advice